Lunit Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 312

Employees

  • Stock Symbol
  • 328130

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $12.15
  • (As of Friday Closing)

Lunit General Information

Description

Lunit Inc is a medical AI software company devoted to providing AI-powered total cancer care. Its products comprise of Lunit INSIGHT CXR, AI solution for Chest x-ray; Lunit INSIGHT MMG, AI solution for Mammography; Lunit SCOPE IO, AI-Powered Biomarker for Immuno-Oncology; and Lunit SCOPE PD-L1, AI Solution for PD-L1 Expression.

Contact Information

Website
www.lunit.io
Formerly Known As
Cldi
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 4th Floor to 9th Floor, 374 Gangnam-daero
  • Gangnam
  • Seoul, 06241
  • South Korea
Primary Industry
Decision/Risk Analysis
Stock Exchange
KRX
Vertical(s)
Corporate Office
  • 4th Floor to 9th Floor, 374 Gangnam-daero
  • Gangnam
  • Seoul, 06241
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lunit Stock Performance

As of 20-Nov-2026, Lunit’s stock price is $12.15. Its current market cap is $905M with 74.5M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$12.15 $12.53 $5.74 - $16.63 $905M 74.5M 1.49M -$1.14

Lunit Financials Summary

As of 30-Sep-2026, Lunit has a trailing 12-month revenue of $64.7M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 545,410 884,419 1,240,631 1,783,856
Revenue 64,716 58,413 39,708 19,183
EBITDA (43,308) (8,307) (47,937) (25,790)
Net Income (70,532) (33,299) (60,608) (28,145)
Total Assets 319,761 256,881 293,906 207,903
Total Debt 62,876 77,488 49,186 15,413
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lunit Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lunit‘s full profile, request access.

Request a free trial

Lunit Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Lunit Inc is a medical AI software company devoted to providing AI-powered total cancer care. Its products comprise of L
Decision/Risk Analysis
Seoul, South Korea
312 As of 2025

Mountain View, CA
 

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lunit Competitors (15)

One of Lunit’s 15 competitors is HeartFlow, a Formerly VC-backed company based in Mountain View, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HeartFlow Formerly VC-backed Mountain View, CA
Vista (Decision/Risk Analysis) Venture Capital-Backed Redwood City, CA
Paige Formerly VC-backed New York, NY
DeepWise (Enterprise Systems) Venture Capital-Backed Beijing, China
HealthMyne Formerly VC-backed Madison, WI
You’re viewing 5 of 15 competitors. Get the full list »

Lunit Patents

Lunit Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026177336-A1 Method and device for outputting medical information about subject by using machine-learning model Pending 21-Feb-2025
EP-4797222-A1 Method and apparatus for analyzing pathological slide image Pending 19-Feb-2025
US-20260245385-A1 Method and apparatus for analyzing pathological slide image Pending 19-Feb-2025
JP-2026139036-A Method and apparatus for analyzing pathology slide images Pending 19-Feb-2025
WO-2026151096-A1 Method and apparatus for outputting medical information Pending 09-Jan-2025
To view Lunit’s complete patent history, request access »

Lunit Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lunit Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lunit‘s full profile, request access.

Request a free trial

Lunit Investments & Acquisitions (2)

Lunit’s most recent deal was a Corporate Asset Purchase with Prognosia (Core Technology Asset in Seoul, South Korea). The deal was made on 01-Jun-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Prognosia (Core Technology Asset in Seoul, South Korea) 01-Jun-2025 Corporate Asset Purchase Buildings and Property
Volpara Health Technologies 21-May-2024 Merger/Acquisition Monitoring Equipment
To view Lunit’s complete investments and acquisitions history, request access »

Lunit ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

14.45 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Health Care IT Services

Subindustry

of 50

Rank

Percentile

To view Lunit’s complete esg history, request access »

Lunit Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Volpara Health Technologies Wellington, New Zealand 2009

Lunit FAQs

  • When was Lunit founded?

    Lunit was founded in 2013.

  • Where is Lunit headquartered?

    Lunit is headquartered in Seoul, South Korea.

  • What is the size of Lunit?

    Lunit has 312 total employees.

  • What industry is Lunit in?

    Lunit’s primary industry is Decision/Risk Analysis.

  • Is Lunit a private or public company?

    Lunit is a Public company.

  • What is Lunit’s stock symbol?

    The ticker symbol for Lunit is 328130.

  • What is the current stock price of Lunit?

    As of 20-Nov-2026 the stock price of Lunit is $12.15.

  • What is the current market cap of Lunit?

    The current market capitalization of Lunit is $905M.

  • What is Lunit’s current revenue?

    The trailing twelve month revenue for Lunit is $64.7M.

  • Who are Lunit’s competitors?

    HeartFlow, Vista (Decision/Risk Analysis), Paige, DeepWise (Enterprise Systems), and HealthMyne are some of the 15 competitors of Lunit.

  • What is Lunit’s annual earnings per share (EPS)?

    Lunit’s EPS for 12 months was -$1.14.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process